Avricore Health (AVCRF) Cost of Revenue (2015 - 2025)

Avricore Health (AVCRF) has 11 years of Cost of Revenue data on file, last reported at $65600.6 in Q3 2025.

• Cost of Revenue for Q3 2025 came in at $65600.6, down 88.23% year-over-year; the trailing twelve-month figure through Sep 2025 was $739546.2 (down 65.63% YoY), and the FY2025 annual result was $211559.4, down 90.03% from the prior year.
• Cost of Revenue advanced to $65600.6 in Q3 2025 per AVCRF's latest filing, from $55418.1 in the prior quarter.
• Over five years, Cost of Revenue peaked at $626512.5 in Q4 2023 and troughed at $4683.7 in Q1 2021.
• A 5-year average of $247702.9 and a median of $165369.4 in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue jumped 2801.41% in 2022, then tumbled 88.76% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $20526.0 in 2021, then jumped by 2801.41% to $595543.3 in 2022, then gained by 5.2% to $626512.5 in 2023, then slipped by 11.04% to $557363.2 in 2024, then slumped by 88.23% to $65600.6 in 2025.
• Business Quant data shows AVCRF's Cost of Revenue at $65600.6 in Q3 2025, $55418.1 in Q2 2025, and $61164.2 in Q1 2025.